Stefan Mullner

This inventor holds 23 USPTO granted patents, plus 1 CIPO patent. Top assignees: Hoechst Aktiengesellschaft, Adventis Research & Technologies Gmbh & Co. Kg, Heochst Aktiengesellschaft. Active years: 1990-2000.

USPTO Granted Patents = 23

% Patents Active = 100.0

CIPO Patents = 1

Average Co-Inventor Count = 2.6

ph-index = 10

Forward Citations = 315(Granted Patents)

Location History:

Frankfurt-am-Main, DE (1990 - 1996)
Hochheim am Main, DE (1993 - 1998)
Hochheim, DE (1993 - 2000)
Hocheim am Main, DE (2000)

Company Filing History:

20 out of 6,705

Hoechst Aktiengesellschaft

patents

1 out of 1

Adventis Research & Technologies Gmbh & Co. Kg

patent

1 out of 3

Heochst Aktiengesellschaft

patents

4. 1 out of 834,411

Other

patents

Years Active: 1990-2000

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6140365 - Preparation of microorganisms comprising omega-3-fatty acid for use as a (2000-10-31),

2. 6121479 - Isoxazole and crotonamide derivatives and their use as pharmaceuticals (2000-09-19),

3. 6036948 - Polyaspartamide derivatives as adsordents for bile acids, (2000-03-14),

4. 6011051 - Use of isoxazole and crotonamide derivatives for the modulation of (2000-01-04),

5. 5990103 - Combination preparation for use in immunological diseases (1999-11-23),

6. 5981536 - Use of xanthine derivatives for the modulation of apoptosis (1999-11-09),

7. 5977151 - Isoxazole and crotonamide derivatives and their use as pharmaceuticals (1999-11-02),

8. 5976811 - Antibodies for the selective immunological determination of bile acids (1999-11-02),

9. 5856330 - Use of xanthine derivatives for the inhibition of dephosphorylation of (1999-01-05),

10. 5780592 - Compositions comprising lipoproteins and crotonamide derivatives (1998-07-14),

11. 5750679 - Process for obtaining pharmacologically active compounds from complex (1998-05-12),

12. 5728686 - Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their (1998-03-17),

13. 5714138 - Polyaspartamide derivatives as adsorbents for bile acids, (1998-02-03),

14. 5624903 - Phosphoinositol-glycan-peptide with insulin-like action (1997-04-29),

15. 5514599 - Antibodies against highly conserved amino acid sequences of insulin a (1996-05-07),

Title: Stefan Mullner - Innovative Inventor from Hochheim

Introduction: Stefan Mullner is a renowned inventor hailing from Hochheim, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Stefan Mullner holds several patents in the fields of renewable energy, sustainable technology, and advanced materials, showcasing his commitment to innovation.

Career Highlights: With a career spanning over two decades, Stefan Mullner has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized the way we approach challenges in the modern world.

Collaborations: Throughout his career, Stefan Mullner has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence that has led to numerous successful projects and inventions.

Conclusion: Stefan Mullner's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.